Oragenics (OGEN) Income from Discontinued Operations (2015 - 2017)

Oragenics (OGEN) has reported Income from Discontinued Operations for 3 consecutive years, with $121.0 the latest figure, recorded in Q2 2017.

• For the quarter ending Q2 2017, Income from Discontinued Operations fell 99.99% year-over-year to $121.0; the trailing twelve-month figure through Sep 2017 stood at $9386.0 (down 99.36% YoY), and the FY2016 full-year result was $1.5 million, up 1052.68% from the prior year.
• Income from Discontinued Operations grew to $121.0 in Q2 2017 per OGEN's latest filing, from -$121.0 in the prior quarter.
• Across five years, Income from Discontinued Operations topped out at $1.4 million in Q2 2016 and bottomed at -$174.0 in Q4 2015.
• Historically, Income from Discontinued Operations has averaged $161275.8 across 3 years, with a median of $12520.5 in 2015.
• The sharpest annual moves came in 2016 and 2017: Income from Discontinued Operations jumped 10102.09% in 2016, then tumbled 101.09% in 2017.
• Over 3 years, Income from Discontinued Operations stood at -$174.0 in 2015, then jumped by 5494.25% to $9386.0 in 2016, then plunged by 98.71% to $121.0 in 2017.
• According to Business Quant data, Income from Discontinued Operations over the past three periods registered $121.0, -$121.0, and $9386.0 for Q2 2017, Q1 2017, and Q4 2016 respectively.